Advertisement
Canada markets open in 1 hour 42 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7314
    +0.0016 (+0.22%)
     

  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     

  • Bitcoin CAD

    87,367.14
    -3,641.25 (-4.00%)
     

  • CMC Crypto 200

    1,356.65
    -25.93 (-1.87%)
     

  • GOLD FUTURES

    2,341.10
    +2.70 (+0.12%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,472.50
    -192.00 (-1.09%)
     

  • VOLATILITY

    16.29
    +0.32 (+2.00%)
     

  • FTSE

    8,091.34
    +50.96 (+0.63%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6821
    +0.0002 (+0.03%)
     

Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session

Zacks Equity Research

Tilray, Inc. TLRY was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $19.81 –$24.38 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen five negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Tilray currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Tilray, Inc. Price

Tilray, Inc. Price
Tilray, Inc. Price

Tilray, Inc. price | Tilray, Inc. Quote

ADVERTISEMENT

Investors interested in the Medical - Drugs industry may consider Jazz Pharmaceuticals PLC JAZZ, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is TLRY going up? Or down? Predict to see what others think:Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Jazz Pharmaceuticals PLC (JAZZ) : Free Stock Analysis Report
 
Tilray, Inc. (TLRY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research